EDIT
BREAKING: EDIT Reports Narrower Loss for Q4 EPS, vs. $0.21 per share estimated
Editas Medicine reports Q4 loss of $0.06/share, narrower than the $0.21 consensus estimate.
Editas Medicine, Inc (EDIT) Q2 2022
Editas Medicine, Inc (NASDAQ: EDIT) Q2 2022 Earnings Conference
Editas Medicine, Inc (EDIT) Q1 2022
Editas Medicine, Inc (NASDAQ: EDIT) Q1 2022 Earnings Conference
Editas Medicine, Inc (EDIT) Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2021 Results and Corporate Update
Editas Medicine, Inc (NASDAQ: EDIT) Q4 2021 Earnings Conference
Editas Medicine, Inc (EDIT) Editas Medicine to Host Conference Call Discussing Third Quarter 2021 Results and Corporate Update
Editas Medicine, Inc (NASDAQ: EDIT) Q3 2021 Earnings Conference
Editas Medicine, inc (EDIT) Editas Medicine to Host Conference Call Discussing Second Quarter 2021 Results and Corporate Update
Editas Medicine, inc (NASDAQ: EDIT) Q2 2021 Earnings Conference